Subcutaneous injection (compounded prescription) Published clinical protocols report typical dose ranges of 1 to 3 mg subcutaneously, administered daily or several times per week, adjusted for the individual patient by their prescribing provider
While some injectable peptides are entirely foreign to the human body, others, like BPC-157 and TB-500, are synthetic versions of proteins that naturally occur in us, where they play a role in tissue and cellular repair
Kreuzer-Redmer S, Arends D, Schulte JN, Karweina D, Korkuc P, Wltje N, et al
PubMed Sosne G, Qiu P, Goldstein AL, Wheater M
Cycling of up to 4 weeks on and 2 weeks off is a commonly recommended approach
Quick Onset : Administered via an injectable, PT-141 typically takes effect within 3060 minutes